457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

Autor:	P. Fabbro-Peray, S. Hachemane, P. Pueyo, Dominique Larrey, François Blanc, D. Diaz, C. Bapin
Rok vydání:	2004
Předmět:	medicine.medical_specialty Hepatology business.industry Ribavirin Pegylated interferon alpha-2b Gastroenterology Non responders chemistry.chemical_compound chemistry Chronic hepatitis Interferon Internal medicine medicine In patient business medicine.drug
Zdroj:	Journal of Hepatology. 40:135
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(04)90457-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5cc532aa85e73e84481e98e000556f48 https://doi.org/10.1016/s0168-8278(04)90457-6 Zobrazit plný text záznamu Full Text from ScienceDirect